blank
blank

ERDERA Policy Brief: European Biotech Act

1:1
The European Rare Diseases Research Alliance (ERDERA), together with the European Reference Networks (ERNs), provides the missing operational layer required to implement the European Biotech Act across the full innovation pathway —from discovery to patient access.

This ERDERA policy brief frames rare diseases as a strategic test case for the proposed European Biotech Act, arguing that fragmented clinical, regulatory, and data ecosystems hinder translation from discovery to patient access. It identifies gaps in the draft Act (including limited recognition of existing infrastructures, narrow biotechnology scope, underdeveloped data frameworks, and skills shortages) and positions the combined ERDERA–European Reference Networks ecosystem as an operational backbone.

It provides seven policy recommendations spanning governance embedding, broader biotech definitions (including RNA, nanomedicine, and AI-enabled technologies), stronger interoperable data infrastructures, support for equitable multinational trials, skills initiatives, and improved investment conditions.

Acces this publication
blank

publication

ERDERA Policy Brief

Year of publication

2026

Source

European Rare Diseases Research Alliance (ERDERA)

Author

You might also be interested in

European Human Genetics Conference - Rotterdam, The Netherlands June 12-15, 2027

European Human Genetics Conference 2027

June 12 - June 15
The conference will take place in Rotterdam on 12–15 June 2027 and is planned as a hybrid event by the European Society of Human Genetics.
uropean Human Genetics Conference (ESHG) 2026

At ESHG 2026 in Gothenburg, ERDERA’s diagnostics work reviewed early progress and the next phase ahead

At the European Human Genetics Conference 2026 in Gothenburg, ERDERA’s Diagnostic Research Workstream reviewed progress, highlighted early results and used a major European genetics meeting to examine how advances in data sharing and genomic analysis may strengthen rare disease diagnosis across countries.
WODC Boston 2026

At World Orphan Drug Congress USA, ERDERA highlights how connected clinical research networks can make rare disease trials more feasible

Boston, 9–11 June 2026: ERDERA's Scientific Coordinator joined the World Orphan Drug Congress USA to set out how stronger clinical research networks can make rare disease trials more feasible across sites and borders.
image (3)

Event Report: 2nd International Conference on Clinical Research Networks (CRNs) for Rare Diseases

The 2nd International Conference on Clinical Research Networks (CRNs), organised by European Rare Diseases Research Alliance (ERDERA), Rare Disease International (RDI) and International Rare Diseases Research Consortium (IRDiRC), brought together the global rare disease community to advance innovative clinical research solutions, with a special focus on low- and middle-income countries (LMICs).

ERDERA's

search form